0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Presidential Address | 
Ashby C. Moncure, MD
Arch Surg. 2001;136(4):376-382. doi:10.1001/archsurg.136.4.376.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Subscribe to the journal
From The JAMA Network
JAMA Neurology
Case Report/Case Series  | 
Natalizumab Use During the Third Trimester of Pregnancy
Aiden Haghikia, MD; Annette Langer-Gould, MD, PhD; Georg Rellensmann, MD; et al.
JAMA Neurology
Review  | 
Immunophenotyping of Cerebrospinal Fluid Cells in Multiple Sclerosis:  In Search of Biomarkers
Sascha Alvermann, MD; Christian Hennig, MD; Olaf Stüve, MD, PhD; et al.
JAMA Neurology
Editorial  | 
Magnetic Resonance Spectroscopy:  A Possible In Vivo Marker of Disease Progression for Multiple Sclerosis?
David H. Miller, MD
JAMA Neurology
Original Investigation  | 
Magnetic Resonance Spectroscopy Markers of Disease Progression in Multiple Sclerosis
Sara Llufriu, MD, PhD; John Kornak, PhD; Helene Ratiney, PhD; et al.